Selectivity data for probe TP-051 and control TP-051n
Jump to control PDSP data
TP-051
Compound concentration: 10 µM| Receptor | HGNC target name | Inhibition [%] (Primary experimental value) | Ki [nM] (Secondary experimental value) | pKi |
|---|---|---|---|---|
| 5-HT1A | HTR1A | 1.37 | ||
| 5-HT1E | HTR1E | 3.83 | ||
| 5-HT2A | HTR2A | 7.36 | ||
| 5-HT2B | HTR2B | 21.48 | ||
| 5-HT2C | HTR2C | 14.08 | ||
| 5-HT3 | HTR3A | 6.06 | ||
| 5-HT5A | HTR5A | 13.33 | ||
| 5-HT6 | HTR6 | -7.86 | ||
| 5-HT7A | HTR7 | 2.66 | ||
| Alpha1A | ADRA1A | -19.46 | ||
| Alpha1B | ADRA1B | 0.86 | ||
| Alpha1D | ADRA1D | 50.81 | 7519.69 | 5.12 |
| Alpha2A | ADRA2A | 13.03 | ||
| Alpha2B | ADRA2B | 13.10 | ||
| Alpha2C | ADRA2C | 5.47 | ||
| Beta1 | ADRB1 | 14.41 | ||
| Beta2 | ADRB2 | -36.94 | > 10000.00 | < 5.00 |
| GABAA/BZP | 23.68 | |||
| D1 | DRD1 | 13.71 | ||
| D2 | DRD2 | 16.59 | ||
| D3 | DRD3 | 59.59 | 924.70 | 6.03 |
| D4 | DRD4 | 85.41 | 1225.46 | 5.91 |
| D5 | DRD5 | 32.24 | ||
| DAT | SLC6A3 | 53.67 | > 10000.00 | < 5.00 |
| DOR | OPRD1 | -12.09 | ||
| H1 | HRH1 | 12.01 | ||
| H3 | HRH3 | 21.10 | ||
| H4 | HRH4 | 10.80 | ||
| KOR | OPRK1 | 10.17 | ||
| M1 | CHRM1 | 15.85 | ||
| M2 | CHRM2 | 2.31 | ||
| M3 | CHRM3 | -0.18 | ||
| M4 | CHRM4 | -16.38 | ||
| M5 | CHRM5 | 20.38 | ||
| MOR | OPRM1 | 1.32 | ||
| NET | SLC6A2 | 19.13 | ||
| GABA/PBR | -0.04 | |||
| SERT | SLC6A4 | -27.60 | ||
| Sigma 1 | SIGMAR1 | 8.90 | ||
| Sigma 2 | TMEM97 | 19.61 | ||
| 5-HT1B | HTR1B | 19.32 | ||
| 5-HT1D | HTR1D | 35.77 | ||
| Beta3 | ADRB3 | -5.43 | ||
| H2 | HRH2 | 5.95 |
TP-051n
Compound concentration: 10 µM| Receptor | HGNC target name | Inhibition [%] (Primary experimental value) | Ki [nM] (Secondary experimental value) | pKi |
|---|---|---|---|---|
| 5-HT1A | HTR1A | -6.09 | ||
| 5-HT1E | HTR1E | -1.42 | ||
| 5-HT2A | HTR2A | -10.88 | ||
| 5-HT2B | HTR2B | 3.00 | ||
| 5-HT2C | HTR2C | -12.10 | ||
| 5-HT3 | HTR3A | -5.96 | ||
| 5-HT5A | HTR5A | -24.79 | ||
| 5-HT6 | HTR6 | -22.62 | ||
| 5-HT7A | HTR7 | -19.11 | ||
| Alpha1A | ADRA1A | -29.11 | ||
| Alpha1B | ADRA1B | -18.88 | ||
| Alpha1D | ADRA1D | -27.43 | ||
| Alpha2A | ADRA2A | 13.08 | ||
| Alpha2B | ADRA2B | -0.21 | ||
| Alpha2C | ADRA2C | -4.04 | ||
| Beta1 | ADRB1 | -0.49 | ||
| Beta2 | ADRB2 | -17.64 | ||
| GABAA/BZP | 19.51 | |||
| D1 | DRD1 | 20.90 | ||
| D2 | DRD2 | 8.60 | ||
| D3 | DRD3 | 7.34 | ||
| D4 | DRD4 | 7.27 | ||
| D5 | DRD5 | 17.53 | ||
| DAT | SLC6A3 | 42.25 | ||
| DOR | OPRD1 | -7.07 | ||
| H1 | HRH1 | -2.18 | ||
| H3 | HRH3 | 6.70 | ||
| H4 | HRH4 | 17.43 | ||
| KOR | OPRK1 | 4.04 | ||
| M1 | CHRM1 | -1.50 | ||
| M2 | CHRM2 | -24.00 | ||
| M3 | CHRM3 | -16.32 | ||
| M4 | CHRM4 | -4.72 | ||
| M5 | CHRM5 | -4.74 | ||
| MOR | OPRM1 | -7.84 | ||
| NET | SLC6A2 | -18.15 | ||
| GABA/PBR | -94.26 | 2752.33 | 5.56 | |
| SERT | SLC6A4 | -11.14 | ||
| Sigma 1 | SIGMAR1 | 16.71 | ||
| Sigma 2 | TMEM97 | 1.49 | ||
| 5-HT1B | HTR1B | 23.18 | ||
| 5-HT1D | HTR1D | 29.53 | ||
| Beta3 | ADRB3 | 6.71 | ||
| H2 | HRH2 | 7.66 |
TP-051
Results are significant for > 50 % inhibition.
Conclusion: Closest off-target is TBXA2R with 60 % inhibition.
| Target protein | HGNC name | Species | Cmp. conc. | % inhibition | Reference compound name | Reference compound IC50 [nM] | Assay ID |
|---|---|---|---|---|---|---|---|
| Adenosine A1 | ADORA1 | Homo sapiens | 10 µM | -1.0 | R(-)-PIA | 830.00 | 200510 |
| Adenosine A2A | ADORA2A | Homo sapiens | 10 µM | 5.0 | CGS-21680 | 130.00 | 200610 |
| Adenosine A3 | ADORA3 | Homo sapiens | 10 µM | 5.0 | IB-MECA | 0.78 | 200720 |
| Adrenergic α1, Non-selective | Rattus sp. | 10 µM | -2.0 | 203500 | |||
| Adrenergic α2, Non-selective | Rattus sp. | 10 µM | 8.0 | 203900 | |||
| Adrenergic beta1 | ADRB1 | Homo sapiens | 10 µM | 5.0 | S(-)-Propranolol | 2.50 | 204010 |
| Adrenergic beta2 | ADRB2 | Homo sapiens | 10 µM | 3.0 | S(-)-Propranolol | 0.78 | 204110 |
| Adrenergic beta3 | ADRB3 | Homo sapiens | 10 µM | 15.0 | Alprenolol | 180.00 | 204200 |
| Angiotensin AT1 | AGTR1 | Homo sapiens | 10 µM | 14.0 | Saralasin | 0.64 | 210020 |
| Angiotensin AT2 | AGTR2 | Homo sapiens | 10 µM | -4.0 | Saralasin | 0.28 | 210110 |
| Bradykinin B1 | BDKRB1 | Homo sapiens | 10 µM | 14.0 | (Des-Arg10)-Kallidin | 0.87 | 212510 |
| Bradykinin B2 | BDKRB2 | Homo sapiens | 10 µM | 7.0 | Bradykinin | 0.89 | 212610 |
| Calcium Channel L-Type, Benzothiazepine | CACNA1C | Rattus sp. | 10 µM | -3.0 | Diltiazem | 0.04 | 214510 |
| Calcium Channel L-Type, Dihydropyridine | CACNA1C | Rattus sp. | 10 µM | 7.0 | Nitrendipine | 0.72 | 214600 |
| Calcium Channel L-Type, Phenylalkylamine | CACNA1C | Rattus sp. | 10 µM | 3.0 | Methoxyverapamil (D-600) | 22.00 | 215000 |
| Calcium Channel N-Type | CACNA1B | Rattus sp. | 10 µM | -4.0 | ω-Conotoxin GVIA | 0.03 | 216000 |
| Cannabinoid CB1 | CNR1 | Homo sapiens | 10 µM | 8.0 | 217010 | ||
| Chemokine CXCR1/2 (IL-8, Non-selective) | Homo sapiens | 10 µM | 3.0 | 244300 | |||
| Cholecystokinin CCK1 (CCKA) | CCKAR | Homo sapiens | 10 µM | 4.0 | 218010 | ||
| Cholecystokinin CCK2 (CCKB) | CCKBR | Homo sapiens | 10 µM | -16.0 | Sincalide | 0.14 | 218120 |
| Dopamine D1 | DRD1 | Homo sapiens | 10 µM | 24.0 | R(+)-SCH-23390 | 1.40 | 219500 |
| Dopamine D2L | DRD2 | Homo sapiens | 10 µM | -2.0 | Spiperone | 0.26 | 219600 |
| Dopamine D3 | DRD3 | Homo sapiens | 10 µM | -7.0 | Spiperone | 0.36 | 219800 |
| Dopamine D4.2 | DRD4 | Homo sapiens | 10 µM | 9.0 | Spiperone | 29.00 | 219900 |
| Endothelin ETA | EDNRA | Homo sapiens | 10 µM | -2.0 | Endothelin-1 | 0.23 | 224010 |
| Endothelin ETB | EDNRB | Homo sapiens | 10 µM | 0.0 | Endothelin-1 | 0.13 | 224110 |
| Estrogen ERalpha | ESR1 | Homo sapiens | 10 µM | 3.0 | Diethylstilbestrol | 0.77 | 226010 |
| Estrogen ERbeta | ESR2 | Homo sapiens | 10 µM | 20.0 | Diethylstilbestrol | 0.61 | 226050 |
| GABAA, Agonist Site | Rattus sp. | 10 µM | 3.0 | 4-aminobutyric acid | 0.03 | 226500 | |
| GABAA, Benzodiazepine, Central | Rattus sp. | 10 µM | -12.0 | Hydrogen diazepam chloride | 0.02 | 226600 | |
| GABAA, Chloride Channel, TBOB | Rattus sp. | 10 µM | 21.0 | Picrotoxin | 270.00 | 226810 | |
| GABAB1B | GABBR1 | Homo sapiens | 10 µM | 1.0 | 228700 | ||
| GABAB1A | GABBR1 | Homo sapiens | 10 µM | 7.0 | 228600 | ||
| Glucocorticoid | NR3C1 | Homo sapiens | 10 µM | 0.0 | 232010 | ||
| Glutamate, AMPA | Rattus sp. | 10 µM | 4.0 | L-Glutamic acid | 320.00 | 232600 | |
| Glutamate, Kainate | GRIK2 | Rattus sp. | 10 µM | -10.0 | 232700 | ||
| Glutamate, NMDA, Glycine | Rattus sp. | 10 µM | 8.0 | MDL 105,519 | 22.00 | 232910 | |
| Glutamate, NMDA, Phencyclidine | Rattus sp. | 10 µM | -4.0 | Dizolcipine ((+)-MK-801) | 5.10 | 233000 | |
| Glycine, Strychnine-Sensitive | Rattus sp. | 10 µM | 7.0 | (-)-Strychnine | 8.90 | 239000 | |
| Growth Hormone Secretagogue (GHS, Ghrelin) | GHSR | Homo sapiens | 10 µM | 2.0 | Ghrelin (human) | 0.13 | 239300 |
| Histamine H1 | HRH1 | Homo sapiens | 10 µM | -7.0 | Pyrilamine | 3.30 | 239610 |
| Histamine H2 | HRH2 | Homo sapiens | 10 µM | 26.0 | Tiotidine | 22.00 | 239710 |
| Imidazoline I2, Central | Rattus sp. | 10 µM | -7.0 | Idazoxan | 12.00 | 241000 | |
| Insulin | INSR | Rattus sp. | 10 µM | 7.0 | Insulin | 6.10 | 243000 |
| Muscarinic M1 | CHRM1 | Homo sapiens | 10 µM | -9.0 | 252600 | ||
| Muscarinic M2 | CHRM2 | Homo sapiens | 10 µM | 4.0 | 252700 | ||
| Muscarinic M3 | CHRM3 | Homo sapiens | 10 µM | 4.0 | 252800 | ||
| Nicotinic Acetylcholine | Homo sapiens | 10 µM | -14.0 | Epibatidine | 0.08 | 258590 | |
| Opiate µ (OP3, MOP) | OPRM1 | Homo sapiens | 10 µM | 5.0 | DAMGO | 20.00 | 260410 |
| Opiate, Non-Selective | Rattus sp. | 10 µM | -8.0 | Naloxone | 0.00 | 260500 | |
| Phorbol Ester | Mus musculus | 10 µM | -9.0 | Phorbol myristate acetate | 0.79 | 264500 | |
| Platelet Activating Factor (PAF) | PTAFR | Homo sapiens | 10 µM | 4.0 | PAF | 0.28 | 265010 |
| Potassium Channel [KATP] | KCNJ11 | Cricetinae | 10 µM | 19.0 | Glyburide | 5.70 | 265600 |
| Potassium Channel [SKCA] | Rattus sp. | 10 µM | -5.0 | 24345-16-2 | 265800 | ||
| Progesterone PR-B | PGR | Homo sapiens | 10 µM | 10.0 | Progesterone | 1.50 | 268020 |
| Prostanoid, Thromboxane A2 (TP) | TBXA2R | Homo sapiens | 10 µM | 60.0 | ICI-19Z,605 | 2.10 | 285510 |
| Serotonin (5-Hydroxytryptamine) 5-HT1, Non-Selective | Rattus sp. | 10 µM | 16.0 | Serotonin (5-HT) | 1.10 | 271000 | |
| Serotonin (5-Hydroxytryptamine) 5-HT2, Non-Selective | Rattus sp. | 10 µM | -15.0 | Ketanserin | 271600 | ||
| Serotonin (5-Hydroxytryptamine) 5-HT3 | HTR3A | Homo sapiens | 10 µM | -3.0 | MDL-72222 | 11.00 | 271910 |
| Serotonin (5-Hydroxytryptamine) 5-HT4 | HTR4 | Cavia porcellus | 10 µM | 8.0 | CHEMBL83954 | 272000 | |
| Sodium Channel, Site 2 | Rattus sp. | 10 µM | 6.0 | Dibucaine | 61.00 | 279510 | |
| Somatostatin sst2 | SSTR2 | Homo sapiens | 10 µM | 5.0 | Somatostatin-14 | 0.01 | 282700 |
| Tachykinin NK1 | TACR1 | Homo sapiens | 10 µM | 17.0 | L-703,606 | 25.00 | 255510 |
| Tachykinin NK2 | TACR2 | Homo sapiens | 10 µM | 29.0 | MEN-10,376 | 110.00 | 255600 |
| Tachykinin NK3 | TACR3 | Homo sapiens | 10 µM | 30.0 | 255700 | ||
| Testosterone | AR | Rattus sp. | 10 µM | 17.0 | 285010 | ||
| Transporter, Dopamine (DAT) | SLC6A3 | Homo sapiens | 10 µM | 5.0 | GBR-12909 | 1.70 | 220320 |
| Transporter, GABA | Rattus sp. | 10 µM | -4.0 | NO-711 | 200.00 | 226400 | |
| Transporter, Norepinephrine (NET) | SLC6A2 | Homo sapiens | 10 µM | 22.0 | Desipramine | 0.93 | 204410 |
| Transporter, Serotonin (5- Hydroxytryptamine) (SERT) | SLC6A4 | Homo sapiens | 10 µM | -5.0 | 274020 | ||
| Vasopressin V1A | AVPR1A | Homo sapiens | 10 µM | 0.0 | 287520 | ||
| Vasopressin V1B | AVPR1B | Homo sapiens | 10 µM | -4.0 | (Arg8)-Vasopressin | 0.66 | 287560 |
| Vasopressin V2 | AVPR2 | Homo sapiens | 10 µM | 0.0 | (Arg8)-Vasopressin | 4.50 | 287610 |
TP-051n
Conclusion: Clean panel.
| Target protein | HGNC name | Species | Cmp. conc. | % inhibition | Reference compound name | Reference compound IC50 [nM] | Assay ID |
|---|---|---|---|---|---|---|---|
| Adenosine A1 | ADORA1 | Homo sapiens | 10 µM | -4.0 | R(-)-PIA | 830.0 | 200510 |
| Adenosine A2A | ADORA2A | Homo sapiens | 10 µM | 10.0 | CGS-21680 | 130.0 | 200610 |
| Adenosine A3 | ADORA3 | Homo sapiens | 10 µM | 0.0 | IB-MECA | 0.8 | 200720 |
| Adrenergic α1, Non-selective | Rattus sp. | 10 µM | -1.0 | 203500 | |||
| Adrenergic α2, Non-selective | Rattus sp. | 10 µM | 6.0 | 203900 | |||
| Adrenergic beta1 | ADRB1 | Homo sapiens | 10 µM | -4.0 | S(-)-Propranolol | 2.5 | 204010 |
| Adrenergic beta2 | ADRB2 | Homo sapiens | 10 µM | -7.0 | S(-)-Propranolol | 0.8 | 204110 |
| Adrenergic beta3 | ADRB3 | Homo sapiens | 10 µM | -3.0 | Alprenolol | 180.0 | 204200 |
| Anaphylatoxin C5a | C5AR1 | Homo sapiens | 10 µM | -1.0 | |||
| Angiotensin AT1 | AGTR1 | Homo sapiens | 10 µM | 1.0 | Saralasin | 0.6 | 210020 |
| Angiotensin AT2 | AGTR2 | Homo sapiens | 10 µM | 1.0 | Saralasin | 0.3 | 210110 |
| Bradykinin B1 | BDKRB1 | Homo sapiens | 10 µM | 19.0 | (Des-Arg10)-Kallidin | 0.9 | 212510 |
| Bradykinin B2 | BDKRB2 | Homo sapiens | 10 µM | -4.0 | Bradykinin | 0.9 | 212610 |
| Calcium Channel L-Type, Benzothiazepine | CACNA1C | Rattus sp. | 10 µM | 5.0 | Diltiazem | 0.0 | 214510 |
| Calcium Channel L-Type, Dihydropyridine | CACNA1C | Rattus sp. | 10 µM | -3.0 | Nitrendipine | 0.7 | 214600 |
| Calcium Channel L-Type, Phenylalkylamine | CACNA1C | Rattus sp. | 10 µM | -1.0 | Methoxyverapamil (D-600) | 22.0 | 215000 |
| Calcium Channel N-Type | CACNA1B | Rattus sp. | 10 µM | -9.0 | ω-Conotoxin GVIA | 0.0 | 216000 |
| Cannabinoid CB1 | CNR1 | Homo sapiens | 10 µM | -6.0 | R(+)-WIN-55,212-2 | 12.0 | 217020 |
| Chemokine CXCR1/2 (IL-8, Non-selective) | Homo sapiens | 10 µM | 4.0 | ||||
| Cholecystokinin CCK1 (CCKA) | CCKAR | Homo sapiens | 10 µM | -9.0 | |||
| Cholecystokinin CCK2 (CCKB) | CCKBR | Homo sapiens | 10 µM | 5.0 | Sincalide | 0.1 | 218120 |
| Dopamine D1 | DRD1 | Homo sapiens | 10 µM | -3.0 | R(+)-SCH-23390 | 1.4 | 219500 |
| Dopamine D2L | DRD2 | Homo sapiens | 10 µM | -4.0 | Spiperone | 0.3 | 219600 |
| Dopamine D3 | DRD3 | Homo sapiens | 10 µM | 4.0 | Spiperone | 0.4 | 219800 |
| Dopamine D4.2 | DRD4 | Homo sapiens | 10 µM | 6.0 | Spiperone | 29.0 | 219900 |
| Endothelin ETA | EDNRA | Homo sapiens | 10 µM | -2.0 | Endothelin-1 | 0.2 | 224010 |
| Endothelin ETB | EDNRB | Homo sapiens | 10 µM | 15.0 | Endothelin-1 | 0.1 | 224110 |
| Estrogen ERalpha | ESR1 | Homo sapiens | 10 µM | 7.0 | Diethylstilbestrol | 0.8 | 226010 |
| Estrogen ERbeta | ESR2 | Homo sapiens | 10 µM | 8.0 | Diethylstilbestrol | 0.6 | 226050 |
| GABAA, Agonist Site | Rattus sp. | 10 µM | 8.0 | 4-aminobutyric acid | 0.0 | 226500 | |
| GABAA, Benzodiazepine, Central | Rattus sp. | 10 µM | -1.0 | Hydrogen diazepam chloride | 0.0 | 226600 | |
| GABAA, Chloride Channel, TBOB | Rattus sp. | 10 µM | 14.0 | Picrotoxin | 270.0 | 226810 | |
| GABAB1B | GABBR1 | Homo sapiens | 10 µM | 10.0 | |||
| GABAB1A | GABBR1 | Homo sapiens | 10 µM | 20.0 | |||
| Glucocorticoid | NR3C1 | Homo sapiens | 10 µM | 14.0 | |||
| Glutamate, AMPA | Rattus sp. | 10 µM | -3.0 | L-Glutamic acid | 320.0 | 232600 | |
| Glutamate, Kainate | GRIK2 | Rattus sp. | 10 µM | 8.0 | 232700 | ||
| Glutamate, NMDA, Glycine | Rattus sp. | 10 µM | 7.0 | MDL 105,519 | 22.0 | 232910 | |
| Glutamate, NMDA, Phencyclidine | Rattus sp. | 10 µM | 5.0 | Dizolcipine ((+)-MK-801) | 5.1 | 233000 | |
| Glycine, Strychnine-Sensitive | Rattus sp. | 10 µM | 5.0 | (-)-Strychnine | 8.9 | 239000 | |
| Growth Hormone Secretagogue (GHS, Ghrelin) | GHSR | Homo sapiens | 10 µM | -1.0 | Ghrelin (human) | 0.1 | 239300 |
| Histamine H1 | HRH1 | Homo sapiens | 10 µM | 2.0 | Pyrilamine | 3.3 | 239610 |
| Histamine H2 | HRH2 | Homo sapiens | 10 µM | 2.0 | Tiotidine | 22.0 | 239710 |
| Imidazoline I2, Central | Rattus sp. | 10 µM | 3.0 | Idazoxan | 12.0 | 241000 | |
| Insulin | INSR | Rattus sp. | 10 µM | 0.0 | Insulin | 6.1 | 243000 |
| Muscarinic M1 | CHRM1 | Homo sapiens | 10 µM | -7.0 | |||
| Muscarinic M2 | CHRM2 | Homo sapiens | 10 µM | -3.0 | |||
| Muscarinic M3 | CHRM3 | Homo sapiens | 10 µM | 1.0 | |||
| Nicotinic Acetylcholine | Homo sapiens | 10 µM | -5.0 | Epibatidine | 0.1 | 258590 | |
| Opiate µ (OP3, MOP) | OPRM1 | Homo sapiens | 10 µM | 10.0 | DAMGO | 20.0 | 260410 |
| Opiate, Non-Selective | Rattus sp. | 10 µM | 3.0 | Naloxone | 0.0 | 260500 | |
| Phorbol Ester | Mus musculus | 10 µM | -3.0 | Phorbol myristate acetate | 0.8 | 264500 | |
| Platelet Activating Factor (PAF) | PTAFR | Homo sapiens | 10 µM | 2.0 | PAF | 0.3 | 265010 |
| Potassium Channel [KATP] | KCNJ11 | Cricetinae | 10 µM | -3.0 | Glyburide | 5.7 | 265600 |
| Potassium Channel [SKCA] | Rattus sp. | 10 µM | 1.0 | 24345-16-2 | 265800 | ||
| Progesterone PR-B | PGR | Homo sapiens | 10 µM | 6.0 | Progesterone | 1.5 | 268020 |
| Prostanoid, Thromboxane A2 (TP) | TBXA2R | Homo sapiens | 10 µM | 28.0 | ICI-19Z,605 | 2.1 | 285510 |
| Serotonin (5-Hydroxytryptamine) 5-HT1, Non-Selective | Rattus sp. | 10 µM | -9.0 | Serotonin (5-HT) | 1.1 | 271000 | |
| Serotonin (5-Hydroxytryptamine) 5-HT2, Non-Selective | Rattus sp. | 10 µM | -3.0 | Ketanserin | 271600 | ||
| Serotonin (5-Hydroxytryptamine) 5-HT3 | HTR3A | Homo sapiens | 10 µM | -11.0 | MDL-72222 | 11.0 | 271910 |
| Serotonin (5-Hydroxytryptamine) 5-HT4 | HTR4 | Cavia porcellus | 10 µM | -8.0 | CHEMBL83954 | 272000 | |
| Sodium Channel, Site 2 | Rattus sp. | 10 µM | -5.0 | Dibucaine | 61.0 | 279510 | |
| Somatostatin sst2 | SSTR2 | Homo sapiens | 10 µM | -6.0 | Somatostatin-14 | 0.0 | 282700 |
| Tachykinin NK1 | TACR1 | Homo sapiens | 10 µM | 3.0 | L-703,606 | 25.0 | 255510 |
| Tachykinin NK2 | TACR2 | Homo sapiens | 10 µM | 3.0 | MEN-10,376 | 110.0 | 255600 |
| Tachykinin NK3 | TACR3 | Homo sapiens | 10 µM | 10.0 | 255710 | ||
| Testosterone | AR | Rattus sp. | 10 µM | 26.0 | 285010 | ||
| Transporter, Dopamine (DAT) | SLC6A3 | Homo sapiens | 10 µM | -8.0 | GBR-12909 | 1.7 | 220320 |
| Transporter, GABA | Rattus sp. | 10 µM | 7.0 | NO-711 | 200.0 | 226400 | |
| Transporter, Norepinephrine (NET) | SLC6A2 | Homo sapiens | 10 µM | 5.0 | Desipramine | 0.9 | 204410 |
| Transporter, Serotonin (5- Hydroxytryptamine) (SERT) | SLC6A4 | Homo sapiens | 10 µM | 2.0 | Fluoxetine | 8.6 | 274030 |
| Vasopressin V1A | AVPR1A | Homo sapiens | 10 µM | -4.0 | 287520 | ||
| Vasopressin V1B | AVPR1B | Homo sapiens | 10 µM | -4.0 | (Arg8)-Vasopressin | 0.7 | 287560 |
| Vasopressin V2 | AVPR2 | Homo sapiens | 10 µM | -23.0 | (Arg8)-Vasopressin | 4.5 | 287610 |
TP-051
Results are significant for > 50 % inhibition.
Conclusion: Closest off-targets [% inhibition] are ALOX5 (85 %), EGFR (61 %), MAPK14 (60 %) and TBXAS1 (64 %)
| Target protein | HGNC name | Species | Cmp. conc. | % inhibition | Reference compound name | Reference compound IC50 [µM] | Assay ID |
|---|---|---|---|---|---|---|---|
| Cholinesterase, Acetyl, ACES | ACHE | Homo sapiens | 10 µM | -15.0 | Physostigmine | 0.12 | 104010 |
| ATPase, Ca2+ | Rattus sp. | 10 µM | -1.0 | 107490 | |||
| ATPase, Na+/K+ | Canis lupus familiaris | 10 µM | 4.0 | 107700 | |||
| Carbonic Anhydrase | Homo sapiens | 10 µM | 27.0 | 112000 | |||
| Cyclooxygenase COX-1 | PTGS1 | Homo sapiens | 10 µM | 14.0 | Indomethacin | 0.04 | 116020 |
| Cyclooxygenase COX-2 | PTGS2 | Homo sapiens | 10 µM | -5.0 | Rofecoxib | 0.17 | 118010 |
| HMG-CoA Reductase | HMGCR | Rattus sp. | 10 µM | -5.0 | 124000 | ||
| Lipoxygenase 5-LO | ALOX5 | Homo sapiens | 10 µM | 85.0 | NDGA | 0.13 | 136010 |
| Monoamine Oxidase MAO-A | MAOA | Homo sapiens | 10 µM | 7.0 | Clorgyline | 0.00 | 140010 |
| Monoamine Oxidase MAO-B | MAOB | Homo sapiens | 10 µM | 6.0 | R(-)-Deprenyl | 0.01 | 140120 |
| Nitric Oxide Synthase, Inducible (iNOS) | NOS2 | Mus musculus | 10 µM | -4.0 | S-Methylisothiourea | 2.30 | 144000 |
| Nitric Oxide Synthase, Neuronal (nNOS) | NOS1 | Rattus sp. | 10 µM | -7.0 | S-methylisothiourea | 142000 | |
| Peptidase, Angiotensin Converting Enzyme | ACE | Oryctolagus cuniculus | 10 µM | 20.0 | Captopril | 0.01 | 107300 |
| Peptidase, CTSG (Cathepsin G) | CTSG | Homo sapiens | 10 µM | 20.0 | Chymostatin | 2.10 | 112510 |
| Peptidase, Factor VIIa | F7 | Homo sapiens | 10 µM | -10.0 | UNII-N62UL02WW4 | 0.71 | 113500 |
| Peptidase, Factor Xa | F10 | Homo sapiens | 10 µM | 2.0 | UNII-N62UL02WW4 | 0.28 | 113600 |
| Peptidase, Matrix Metalloproteinase-1 (MMP-1) | MMP1 | Homo sapiens | 10 µM | 2.0 | TIMP-2 | 0.01 | 114110 |
| Peptidase, Matrix Metalloproteinase-7 (MMP-7) | MMP7 | Homo sapiens | 10 µM | 1.0 | GM-6001 | 114710 | |
| Peptidase, Matrix Metalloproteinase-13 (MMP-13) | MMP13 | Homo sapiens | 10 µM | 5.0 | GM-6001 | 115300 | |
| Peptidase, Matrix Metalloproteinase-14 (MMP-14) | MMP14 | Homo sapiens | 10 µM | 3.0 | GM-6001 | 115400 | |
| Peptidase, Metalloproteinase, Neutral Endopeptidase | MME | Homo sapiens | 10 µM | 4.0 | Phosphoramidon | 0.01 | 164000 |
| Peptidase, Renin | REN | Homo sapiens | 10 µM | -1.0 | 164600 | ||
| Peptidase, Thrombin | F2 | Homo sapiens | 10 µM | -1.0 | UNII-N62UL02WW4 | 0.00 | 165000 |
| Peptidase, Tumor Necrosis Factor-alpha Converting Enzyme (TACE) | ADAM17 | Homo sapiens | 10 µM | 36.0 | Ilomastat | 0.02 | 166500 |
| Phosphodiesterase PDE3 | Homo sapiens | 10 µM | 3.0 | Cilostamide | 0.05 | 152000 | |
| Phosphodiesterase PDE4 | Homo sapiens | 10 µM | 26.0 | Ro 20-1724 | 1.10 | 154000 | |
| Phosphodiesterase PDE5 | PDE5A | Homo sapiens | 10 µM | -6.0 | Zaprinast | 156000 | |
| Phosphodiesterase PDE6 | Bos taurus | 10 µM | 20.0 | Zaprinast | 156100 | ||
| Phospholipase PLA2-I | Sus scrofa | 10 µM | 6.0 | Quinacrine | 130.00 | 160000 | |
| Protein Serine/Threonine Kinase, Ca2+/Calmodulin-Dep.II | Rattus sp. | 10 µM | 44.0 | 168000 | |||
| Protein Serine/Threonine Kinase, cdk1/Cyclin B | Homo sapiens | 10 µM | 14.0 | 168100 | |||
| Protein Serine/Threonine Kinase, MAPK3 (ERK1) | MAPK3 | Homo sapiens | 10 µM | 30.0 | Staurosporine | 1.60 | 171000 |
| Protein Serine/Threonine Kinase, GSK-3β | GSK3B | Homo sapiens | 10 µM | 19.0 | 5-iodo-Indirubin-3'-monoxime | 0.00 | 176500 |
| Protein Serine/Threonine Kinase, MAPK14 (p38α) | MAPK14 | Homo sapiens | 10 µM | 60.0 | SB-Z0Z190 | 0.02 | 176600 |
| Protein Serine/Threonine Kinase, PKA, Non-Selective | Bos taurus | 10 µM | 5.0 | H-7 | 3.60 | 177000 | |
| Protein Serine/Threonine Kinase, PKBα/Akt1 | AKT1 | Homo sapiens | 10 µM | -1.0 | 177500 | ||
| Protein Serine/Threonine Kinase, PKC, Non-Selective | Rattus sp. | 10 µM | -8.0 | Staurosporine | 0.00 | 178010 | |
| Protein Serine/Threonine Phosphatase, Calcineurin, PP2B | PPP3CA | Homo sapiens | 10 µM | 10.0 | 188010 | ||
| Protein Tyrosine Kinase, EGF Receptor | EGFR | Homo sapiens | 10 µM | 61.0 | Tyrphostin 47 | 1.10 | 170010 |
| Protein Tyrosine Kinase, ERBB2 (HER2) | ERBB2 | Homo sapiens | 10 µM | -9.0 | 174000 | ||
| Protein Tyrosine Kinase, Insulin Receptor | INSR | Homo sapiens | 10 µM | -13.0 | Tyrphostin 47 | 3.10 | 175000 |
| Protein Tyrosine Kinase, pp60 c-SRC | SRC | Homo sapiens | 10 µM | 1.0 | Staurosporine | 0.23 | 176800 |
| Steroid 5α-Reductase | Rattus sp. | 10 µM | 19.0 | Finasteride | 0.06 | 193600 | |
| Thromboxane Synthase | TBXAS1 | Homo sapiens | 10 µM | 64.0 | 194010 | ||
| Xanthine Oxidase | XDH | Bos taurus | 10 µM | 1.0 | Allopurinol | 2.40 | 198000 |
TP-051n
Conclusion: Closest off-targets [% inhibition] are LYN (70 %), MAPK14 (66 %) and PKC (-114 %)
| Target protein | HGNC name | Species | Cmp. conc. | % inhibition | Reference compound name | Reference compound IC50 [µM] | Assay ID |
|---|---|---|---|---|---|---|---|
| Cholinesterase, Acetyl, ACES | ACHE | Homo sapiens | 10 µM | -4.0 | Physostigmine | 0.1 | 104010 |
| ATPase, Ca2+, skeletal muscle | Sus scrofa | 10 µM | -2.0 | Cyclopiazonic acid | 0.1 | 107480 | |
| ATPase, Na+/K+, heart | Sus scrofa | 10 µM | -1.0 | Ouabain | 2.0 | 107710 | |
| Carbonic Anhydrase | Homo sapiens | 10 µM | 11.0 | ||||
| Cyclooxygenase COX-1 | PTGS1 | Homo sapiens | 10 µM | -1.0 | Indomethacin | 0.0 | 116020 |
| Cyclooxygenase COX-2 | PTGS2 | Homo sapiens | 10 µM | 17.0 | Rofecoxib | 0.2 | 118010 |
| HMG-CoA Reductase | HMGCR | Rattus sp. | 10 µM | -21.0 | |||
| Lipoxygenase 5-LO | ALOX5 | Homo sapiens | 10 µM | 24.0 | NDGA | 0.1 | 136010 |
| Monoamine Oxidase MAO-A | MAOA | Homo sapiens | 10 µM | 33.0 | Clorgyline | 0.0 | 140010 |
| Monoamine Oxidase MAO-B | MAOB | Homo sapiens | 10 µM | 9.0 | R(-)-Deprenyl | 0.0 | 140120 |
| Nitric Oxide Synthase, Inducible (iNOS) | NOS2 | Mus musculus | 10 µM | -3.0 | S-Methylisothiourea | 2.3 | 144000 |
| Nitric Oxide Synthase, Neuronal (nNOS) | NOS1 | Rattus sp. | 10 µM | 4.0 | S-methylisothiourea | 142000 | |
| Peptidase, Angiotensin Converting Enzyme | ACE | Oryctolagus cuniculus | 10 µM | -5.0 | Captopril | 0.0 | 107300 |
| Peptidase, CTSG (Cathepsin G) | CTSG | Homo sapiens | 10 µM | 11.0 | Chymostatin | 2.1 | 112510 |
| Peptidase, Factor VIIa | F7 | Homo sapiens | 10 µM | 6.0 | UNII-N62UL02WW4 | 0.7 | 113500 |
| Peptidase, Factor Xa | F10 | Homo sapiens | 10 µM | -1.0 | UNII-N62UL02WW4 | 0.3 | 113600 |
| Peptidase, Matrix Metalloproteinase-1 (MMP-1) | MMP1 | Homo sapiens | 10 µM | 3.0 | TIMP-2 | 0.0 | 114110 |
| Peptidase, Matrix Metalloproteinase-7 (MMP-7) | MMP7 | Homo sapiens | 10 µM | 3.0 | GM-6001 | 114710 | |
| Peptidase, Matrix Metalloproteinase-13 (MMP-13) | MMP13 | Homo sapiens | 10 µM | 3.0 | GM-6001 | 115300 | |
| Peptidase, Matrix Metalloproteinase-14 (MMP-14) | MMP14 | Homo sapiens | 10 µM | 5.0 | GM-6001 | 115400 | |
| Peptidase, Metalloproteinase, Neutral Endopeptidase | MME | Homo sapiens | 10 µM | 5.0 | Phosphoramidon | 0.0 | 164000 |
| Peptidase, Renin | REN | Homo sapiens | 10 µM | -10.0 | 164600 | ||
| Peptidase, Thrombin | F2 | Homo sapiens | 10 µM | 5.0 | UNII-N62UL02WW4 | 0.0 | 165000 |
| Peptidase, Tumor Necrosis Factor-alpha Converting Enzyme (TACE) | ADAM17 | Homo sapiens | 10 µM | 22.0 | Ilomastat | 0.0 | 166500 |
| Phosphodiesterase PDE3 | Homo sapiens | 10 µM | 12.0 | Cilostamide | 0.1 | 152000 | |
| Phosphodiesterase PDE4 | Homo sapiens | 10 µM | 11.0 | Ro 20-1724 | 1.1 | 154000 | |
| Phosphodiesterase PDE5 | PDE5A | Homo sapiens | 10 µM | 12.0 | Zaprinast | 156000 | |
| Phosphodiesterase PDE6 | Bos taurus | 10 µM | 15.0 | Zaprinast | 156100 | ||
| Phospholipase PLA2-I | Sus scrofa | 10 µM | -2.0 | Quinacrine | 130.0 | 160000 | |
| Protein Serine/Threonine Kinase, Ca2+/Calmodulin-Dep.II | Rattus sp. | 10 µM | 20.0 | ||||
| Protein Serine/Threonine Kinase, ERK2 | MAPK1 | Mus musculus | 10 µM | 9.0 | |||
| Protein Serine/Threonine Kinase, cdk1/Cyclin B | Homo sapiens | 10 µM | -10.0 | ||||
| Protein Serine/Threonine Kinase, MAPK3 (ERK1) | MAPK3 | Homo sapiens | 10 µM | 23.0 | Staurosporine | 1.6 | 171000 |
| Protein Serine/Threonine Kinase, MEK1 | MAP2K1 | Homo sapiens | 11 µM | 16.0 | |||
| Protein Serine/Threonine Kinase, GSK-3β | GSK3B | Homo sapiens | 10 µM | 29.0 | 5-iodo-Indirubin-3'-monoxime | 0.0 | 176500 |
| Protein Serine/Threonine Kinase, IKK-1 | CHUK | Homo sapiens | 10 µM | 31.0 | Staurosporine | 0.1 | 176200 |
| Protein Serine/Threonine Kinase, JNK1α1 | MAPK8 | Homo sapiens | 10 µM | 11.0 | |||
| Protein Serine/Threonine Kinase, MAPK14 (p38α) | MAPK14 | Homo sapiens | 10 µM | 66.0 | SB-Z0Z190 | 0.0 | 176600 |
| Protein Serine/Threonine Kinase, PKA, Non-Selective | Bos taurus | 10 µM | 14.0 | H-7 | 3.6 | 177000 | |
| Protein Serine/Threonine Kinase, PKBα/Akt1 | AKT1 | Homo sapiens | 10 µM | -20.0 | |||
| Protein Serine/Threonine Kinase, PKC, Non-Selective | Rattus sp. | 10 µM | -114.0 | Staurosporine | 0.0 | 178010 | |
| Protein Serine/Threonine Phosphatase, Calcineurin, PP2B | PPP3CA | Homo sapiens | 10 µM | 0.0 | |||
| Protein Tyrosine Kinase, EGF Receptor | EGFR | Homo sapiens | 10 µM | 3.0 | Tyrphostin 47 | 1.1 | 170010 |
| Protein Tyrosine Kinase, ERBB2 (HER2) | ERBB2 | Homo sapiens | 10 µM | 30.0 | |||
| Protein Tyrosine Kinase, Fes | FES | Homo sapiens | 10 µM | 25.0 | |||
| Protein Tyrosine Kinase, Insulin Receptor | INSR | Homo sapiens | 10 µM | -10.0 | Tyrphostin 47 | 3.1 | 175000 |
| Protein Tyrosine Kinase, Lyn B | LYN | Homo sapiens | 10 µM | 70.0 | |||
| Protein Tyrosine Kinase, SRC | SRC | Homo sapiens | 10 µM | 0.0 | Staurosporine | 0.2 | 176800 |
| Steroid 5α-Reductase | Rattus sp. | 10 µM | 21.0 | Finasteride | 0.1 | 193600 | |
| Thromboxane Synthase | TBXAS1 | Homo sapiens | 10 µM | 13.0 | 1-(7-Carboxyheptyl)-Imidazole | 0.0 | 194020 |
| Xanthine Oxidase | XDH | Bos taurus | 10 µM | 24.0 | Allopurinol | 2.4 | 198000 |